• 1
    Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end stage diabetic nephropathy after combined transplantation. Transplantation 1999; 67: 645.
  • 2
    Troisi R, Meester D, Van Den Broecke C, et al. Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine-tryptophan-ketoglutarate (custodiol) or University of Wisconsin solution. Transplantation 2003; 75: 1793.
  • 3
    Reddy KS, Stratta RJ, Shokouh-Amiri MH, Alloway R, Egidi MF, Gaber AO. Surgical complications after pancreas transplantation with portal-enteric drainage. J Am Coll Surg 1999; 189: 305.
  • 4
    Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim E, Dunn DL. The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg 1997; 185: 128.
  • 5
    Randhawa P. Allograft biopsies in management of pancreas transplant recipients. J Postgrad Med 2002; 48: 55.
  • 6
    Ciancio G, Lo Monte A, Julian JF, Romano M, Miller J, Burke GW. Vascular complications following bladder drained, simultaneous pancreas–kidney transplantation: the University of Miami experience. Transplant Int 2000; 13: S187.
  • 7
    Maraschio MA, Kayler RM, Merion RM, et al. Successful surgical salvage of partial pancreatic allograft thrombosis. Transplant Proc 2003; 35: 1491.
  • 8
    Spiros D, Christos D, John B, Burke GW, Miller J, Ciancio G. Vascular complications of pancreas transplantation. Pancreas 2004; 28: 413.
  • 9
    Drachenberg CB, Papadimitriou JC, Farney A, et al. Pancreas transplantation: the histological morphology of graft loss and clinical correlations. Transplantation 2001; 71: 1784.
  • 10
    Schaser K-D, Puhl G, Vollmar B, et al. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation. Am J Transpl 2005; 5: 341.
  • 11
    Wullstein C, Woeste G, Zapletal C, Trobisch H, Bechstein WO. Prothrombotic disorders in uremic type-1 diabetics undergoing simultaneous pancreas and kidney transplantation. Transplantation 2003; 76: 1691.
  • 12
    Hoffmann JN, Mühlbayer D, Jochum M, Inthorn D. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis. Crit Care Med 2004; 32(9): 1851.
  • 13
    Hoffmann JN, Vollmar B, Roemisch J, Inthorn D, Schildberg FW, Menger MD. Antithrombin effects on endotoxin-induced microcirculatory disorders are mainly mediated by its interaction with microvascular endothelium. Crit Care Med 2002; 30: 218.
  • 14
    Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002; 13: 1.
  • 15
    Özden A, Sarioglu A, Demirkan NC, Bilihan A, Düzcan E. Antithrombin III reduces renal ischemia-reperfusion injury in rats. Res Exp Med 2001; 200: 195.
  • 16
    Ostrovsky L, Woodman R, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997; 96: 2302.
  • 17
    Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999; 93: 157.
  • 18
    Langley PG, Hughes RD, Forbes A, Keays R, Williams R. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 1993; 17: 326.
  • 19
    Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transpl 2002; 2: 520.
  • 20
    Arakami O, Takayama T, Yokoyama T, et al. High dose of AT induces indefinite survival of fully allogenic cardiac grafts and generates regulatory cells. Transplantation 2003; 75: 217.
  • 21
    Hoffmann JN, Arbogast HP, Fertmann J, et al. High dose antithrombin therapy reduces ischemia/reperfusion injury during human allogenic kidney transplantation: first results of a randomized controlled clinical trial. Transplantation 2002; 74, 394.
  • 22
    Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 362.
  • 23
    Hoffmann JN, Mühlbayer D, Jochum M, Inthorn D. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis. Crit Care Med 2004; 32: 1851.
  • 24
    Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433.
  • 25
    Rogers J, Chavin KD, Baliga PK, et al. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg 2003; 7: 1096.
  • 26
    Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DE. Technical failures after pancreas transplants: why grafts fail and the risk factors - a multivariate analysis. Transplantation 2004; 78: 1188.
  • 27
    Menger MD, Vollmar B. Role of microcirculation in transplantation. Microcirculation 2000; 7: 291.
  • 28
    Wullstein C, Woeste G, Zapletal C, Dette K, Bechstein WO. Simultaneous pancreas–kidney transplantation in patients with antiphospholipid syndrome. Transplantation 2003; 75: 562.
  • 29
    Waydhas C, Nast Kolb D, Jochum M, et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992; 127: 460.
  • 30
    Benz S, Busing M, Mayer JM, et al. Pancreas graft thrombosis: is there a role for trypsin. Pancreas 2004; 28: 75.
  • 31
    Hopt UT, Busing M, Schareck W. Prevention of early postoperative graft thrombosis in pancreatic transplantation. Transplant Proc 1993; 34: S24.
  • 32
    Tibell A, Brattstrom C, Kozlowski T. Management after clinical pancreatic transplantation with enteric exocrine drainage. Transplant Proc 1994; 26: 1797.
  • 33
    Drognitz O, Liu X, Obermaier R, et al. Ischemic preconditioning fails to improve microcirculation but increases apoptotic cell death in experimental pancreas transplantation. Transplant Int 2004; 17: 317.
  • 34
    Obermaier R, Von Dobschuetz E, Muhs O, et al. Influence of nitric oxide on microcirculation in pancreatic ischemia/reperfusion injury: an intravital microscopic study. Transplant Int 2004; 17: 208.